Division of Nephrology, Department of Medicine, University of California, San Francisco, California, USA,
Division of Pediatric Nephrology, Department of Pediatrics, University of California, San Francisco, California, USA,
Am J Nephrol. 2019;50(2):144-151. doi: 10.1159/000501510. Epub 2019 Jul 3.
Studies of the timing of end-stage renal disease (ESRD) have primarily defined "early" versus "late" initiation of dialysis using estimated glomerular filtration rate (eGFR)-based criteria. Our objective was to determine the theoretical time that could be spent in chronic kidney disease (CKD) stage 5 prior to reaching a conservative eGFR threshold of 5 mL/min/1.73 m2 compared to the actual time spent in CKD stage 5 by risk factors of interest.
Eight-hundred and seventy Chronic Renal Insufficiency Cohort participants with CKD stage 5 who started renal replacement therapy (RRT) were included for retrospective study. We used mixed models to estimate the person-specific trajectory of renal function. We then used these individual trajectories to estimate the amount of time that would be spent in CKD stage 5 (between eGFR of 15 and 5 mL/min/1.73 m2) and compared this estimate to the actual time spent in CKD stage 5 prior to ESRD (between eGFR of 15 mL/min/1.73 m2 and ESRD).
We found the median observed time between eGFR of 15 mL/min/1.73 m2 to RRT was 9.6 months, but the median predicted time between eGFR of 15 mL/min/1.73 m2 to eGFR of 5 mL/min/1.73 m2 was 17.7 months. Some of the largest differences between the predicted and actual amount of time spent in CKD stage 5 were noted among those with systolic blood pressure <140 mm Hg (9.7 months longer predicted compared to actual), proteinuria <1 g/g (9.1 months), and serum albumin ≥3.5 g/dL (9.0 months).
We found marked differences between the actual and predicted time spent in CKD stage 5 based on risk factors of interest. We believe that placing timing of dialysis initiation in the perspective of time is novel and may identify subgroups of patients who may derive particular benefit from a more concerted effort to delay RRT.
研究终末期肾病(ESRD)的时机主要使用基于估算肾小球滤过率(eGFR)的标准来定义“早期”与“晚期”开始透析。我们的目的是确定在达到保守的 eGFR 阈值 5 mL/min/1.73 m2 之前,可以在慢性肾脏病(CKD)5 期度过的理论时间,与感兴趣的风险因素实际花费在 CKD 5 期的时间相比。
纳入 870 名接受肾脏替代治疗(RRT)的 CKD 5 期慢性肾功能不全队列参与者进行回顾性研究。我们使用混合模型估计个体肾功能的轨迹。然后,我们使用这些个体轨迹来估计在 CKD 5 期(eGFR 在 15 至 5 mL/min/1.73 m2 之间)度过的时间量,并将该估计值与 ESRD 前 CKD 5 期(eGFR 在 15 mL/min/1.73 m2 至 ESRD 之间)的实际时间进行比较。
我们发现 eGFR 在 15 mL/min/1.73 m2 到 RRT 之间的观察中位数时间为 9.6 个月,但 eGFR 在 15 mL/min/1.73 m2 到 eGFR 在 5 mL/min/1.73 m2 之间的预测中位数时间为 17.7 个月。在收缩压<140 mm Hg(预测时间比实际时间长 9.7 个月)、蛋白尿<1 g/g(预测时间比实际时间长 9.1 个月)和血清白蛋白≥3.5 g/dL(预测时间比实际时间长 9.0 个月)的患者中,预测和实际 CKD 5 期时间之间的差异最大。
我们发现基于感兴趣的风险因素,实际和预测的 CKD 5 期时间之间存在显著差异。我们认为,从时间角度考虑透析开始的时机是新颖的,可能会确定出可能从更集中精力延迟 RRT 中获益的亚组患者。